Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bryan P Schneider, MD
Indiana University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Memorial Healthcare System
Hollywood, Florida, United States
- Miami Cancer Institute at Baptist Health, Inc.
Miami, Florida, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, United States
- Summit Health
Berkeley Heights, New Jersey, United States
- Novant Health Cancer Institute
Winston-Salem, North Carolina, United States
- Mays Cancer Center at Ut Health San Antonio
San Antonio, Texas, United States
- University of Wisconsin
Madison, Wisconsin, United States
- Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Advocate Aurora Research Institute (illinois)
Wauwatosa, Wisconsin, United States
- Aurora Health Care
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Aug 2021
- Primary completion
- 24 Oct 2024
- Completion
- 2 Dec 2024
- Last update posted
- 31 May 2025
- Registered enrollment
- 52
- Registry id
- NCT04849364
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.